Greystone Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-83,970
Closed -$8.35M 105
2024
Q4
$8.35M Buy
83,970
+70,958
+545% +$7.32M 1.45% 27
2024
Q3
$1.48M Buy
13,012
+3,334
+34% +$396K 0.26% 58
2024
Q2
$1.2M Buy
9,678
+3,257
+51% +$420K 0.23% 58
2024
Q1
$847K Buy
6,421
+1
+0% +$123 0.17% 65
2023
Q4
$700K Sell
6,420
-3
-0% -$311 0.16% 71
2023
Q3
$661K Sell
6,423
-607
-9% -$65.4K 0.17% 69
2023
Q2
$811K Sell
7,030
-67
-0.9% -$7.61K 0.19% 63
2023
Q1
$755K Buy
7,097
+92
+1% +$9.93K 0.19% 62
2022
Q4
$777K Sell
7,005
-220
-3% -$22.5K 0.23% 53
2022
Q3
$622K Buy
+7,225
New +$645K 0.21% 59

Other funds holding MRK

Greystone Financial Group's MRK Position: Q1 2025 in Review

Greystone Financial Group sold out of Merck (MRK) in Q1 2025, closing a stake of 83,970 shares — an estimated $8.35M sold.

Greystone Financial Group first reported a position in MRK in Q3 2022 and held it in 10 quarters. The position peaked at $8.35M in Q4 2024. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Greystone Financial Group reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Greystone Financial Group sold 83,970 Merck shares in Q1 2025, an estimated $8.35M.
  • Greystone Financial Group first reported a position in Merck in Q3 2022 and held it in 10 quarters.
  • Greystone Financial Group's Merck position peaked at $8.35M in Q4 2024.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Greystone Financial Group's 13F filing for Q1 2025, filed 14 Apr 2025.